BioArctic
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
BIOA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010323303 (+1 more)
- LEI:
- 549300Y0OI2WVUNHLC33
- Country:
- Sweden
- Address:
- Warfvinges väg 35, 112 51 Stockholm
- Website:
- https://www.bioarctic.se/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
BioArctic is a Swedish research-intensive biopharmaceutical company focused on developing novel, disease-modifying treatments and diagnostics for neurodegenerative disorders. The company's core mission is to address the underlying causes of diseases such as Alzheimer's and Parkinson's. Its research is centered on developing innovative drugs and antibodies that target the root mechanisms of nerve cell damage and misfolded proteins, aiming to provide effective solutions for significant unmet medical needs within the central nervous system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-24 08:40 |
Australien godkänner Leqembi® för behandling av tidig Alzheimers sjukdom
|
Swedish | 225.9 KB | ||
| 2025-09-03 17:35 |
BioArctics grundare har för avsikt att sälja en mindre del av sitt aktieinnehav
|
Swedish | 182.9 KB | ||
| 2025-09-03 17:35 |
BioArctic’s founders intend to divest minor part of their shareholding
|
English | 179.0 KB | ||
| 2025-09-03 01:30 |
Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as …
|
English | 211.3 KB | ||
| 2025-09-03 01:30 |
Stegvis ansökningsprocess påbörjad för marknadsgodkännande i USA av Leqembi® Iq…
|
Swedish | 253.3 KB | ||
| 2025-09-01 18:30 |
Number of shares and votes in BioArctic AB (publ) as of August 29, 2025
|
English | 196.1 KB | ||
| 2025-09-01 18:30 |
Antal aktier och röster i BioArctic AB (publ) per den 29 augusti 2025
|
Swedish | 209.2 KB | ||
| 2025-08-29 23:56 |
Amerikanska läkemedelsverket godkänner subkutan underhållsbehandling med Leqemb…
|
Swedish | 251.3 KB | ||
| 2025-08-29 23:55 |
US FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for m…
|
English | 212.0 KB | ||
| 2025-08-28 08:00 | Swedish | 1.8 MB | |||
| 2025-08-28 08:00 | English | 1.6 MB | |||
| 2025-08-26 07:05 |
BioArctic och Novartis ingår options-, samarbets- och licensavtal som nyttjar B…
|
Swedish | 201.1 KB | ||
| 2025-08-26 07:05 |
BioArctic and Novartis sign an option, collaboration and license agreement usin…
|
English | 206.8 KB | ||
| 2025-07-31 12:00 |
Sales of Leqembi® totaled 23.1 billion yen in the second quarter 2025
|
English | 196.5 KB | ||
| 2025-07-31 12:00 |
Försäljningen av Leqembi® uppgick till 23,1 miljarder yen under det andra kvart…
|
Swedish | 223.3 KB |
Automate Your Workflow. Get a real-time feed of all BioArctic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioArctic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioArctic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-13 | Gunilla Osswald | Other | Sell | 40,000 | 8,821,200.00 SEK |
| 2025-02-13 | Gunilla Osswald | Other | Other | 40,000 | 3,344,000.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Sell | 6,000 | 1,323,180.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Other | 6,000 | 501,600.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Sell | 1,500 | 330,795.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 2,500 | 209,000.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 1,500 | 125,400.00 SEK |
| 2025-01-10 | Mikael Smedeby | Other | Buy | 730 | 148,920.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 2,000 | 446,000.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 871 | 195,626.60 SEK |
Peer Companies
